Responsibility





Cronos Group is committed to responsibly leading the emerging cannabis and CBD industries by focusing on product quality, limiting access to adult consumers and transparent practices.


In the U.S., we currently sell CBD products derived from hemp. In Canada, we sell adult-use and medicinal cannabis products. Our experience in Canada has prepared us to operate in a strictly regulated environment and provide products that appeal to consumers because of their quality. Our medicinal cannabis products are available in other markets which permit the sale of these products, including Germany, Israel and Australia. We know a lot of questions surround these new and quickly evolving industries, and we believe we have a responsibility to educate consumers, policy makers and regulators.





CBD and Cannabis 101


Get to Know the Basics



What is
Hemp-derived CBD?

In the U.S., hemp is a non-intoxicating form of the Cannabis sativa L. plant, containing not more than 0.3% THC on a dry weight basis. Cannabis sativa L. plants contain many different chemical compounds, known as cannabinoids.

CBD (cannabidiol) is a non-intoxicating cannabinoid found in the Cannabis sativa L. plant.

Expand Icon Normal

What is
Hemp-derived
CBD?

What does
Hemp-derived
CBD do?

Research remains ongoing, but people have reported using CBD for a variety of reasons including self-care. The U.S. FDA has approved a prescription drug, Epidiolex, containing CBD at approximately 10-100x the levels of typical ingestible products, to treat rare severe forms of epilepsy.

Expand Icon Normal

What does
Hemp-derived
CBD do?

What is the status
of Hemp-derived
CBD?

In 2018, U.S. Congress removed hemp containing not more than 0.3% THC on a dry weight basis and hemp-derived products (including CBD and other cannabinoids) from Schedule 1 of the Controlled Substances Act. Canada legalized cannabis and its cannabinoids (including CBD) for adult use in 2018 and for medicinal use in 2001.

Expand Icon Normal

What is the status
of Hemp-derived
CBD?

What is
Cannabis?

Cannabis, also known as marijuana, is a plant that produces cannabinoids (chemical compounds) and terpenes (natural aromatic oils that provide aroma and flavor), which can impact or affect the mind and body.

Tetrahydrocannabinol (THC) is the primary cannabinoid that gives the plant its intoxicating properties and is different from the non-intoxicating cannabinoids like CBD.

Expand Icon Normal

What is
Cannabis?

What does
Cannabis do?

Everyone’s response to cannabis differs and can vary from one time to the next. Available research points to dose, delivery, and unique body and tolerance as factors that may impact experience.

Expand Icon Normal

What does
Cannabis do?

What is the status
of Cannabis?

It is growing in popularity among medicinal patients and adult-users, and researchers and regulators are increasing their engagement on this topic.
Canada legalized medicinal cannabis in 2001 and adult-use in 2018. Some U.S. states have begun to legalize cannabis’ usage for medicinal and/ or adult use. Many countries, including Germany, Israel and Australia, have legalized the use of cannabis for certain medicinal purposes. Activists and elected officials around the world are working to advance cannabis policy.

Expand Icon Normal

What is the status
of Cannabis?





FAQs



Where do you sell your products?
Where can I find your lab reports?
What sort of standards do you meet for your hemp-derived CBD products?
Does CBD have specific health benefits?
How are you supporting CBD research?
What sort of standards do you meet for your cannabis products?
How are you supporting cannabis research?
Is Cronos a member of any industry organizations?




Resources



Responsible use of cannabis entails knowing when consumption is not appropriate. For example, cannabis is not appropriate for those who are below the legal age of consumption, pregnant or nursing, or driving. We defer to medical practitioners when it comes to who should be prescribed medicinal cannabis. The following resources provide important information on these topics.


Underage cannabis use


U.S. Centers for Disease Control and Prevention Fact Sheet – What You Need to Know About Marijuana Use in Teens

Government of Canada – Effects of cannabis on young people’s health


Pregnancy and cannabis use


U.S. Centers for Disease Control and Prevention Fact Sheet – What You Need to Know about Marijuana Use and Pregnancy

Government of Canada – Effects of cannabis on pregnancy and breast feeding


Cannabis and driving


U.S. Centers for Disease Control Fact Sheet – What You Need to Know About Marijuana Use and Driving

Government of Canada – Effects of impaired driving


Addiction


Addiction is also a serious concern. If you believe you or a loved one may be struggling with substance use disorder, consider whether these signs are exhibited. The U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) provides a National Helpline at 1-800-662-HELP (4357) or TTY: 1-800-487-4889. In addition, SAMHSA’s website includes a treatment locator tool.

The Canadian Centre on Substance Use and Addiction provides helplines for different provinces in Canada. This Centre also supports the Wellness Together Canada campaign which includes tools and information for those in need of support.










Quality








Our goal at Cronos Group is to produce high-quality hemp-derived CBD products that our customers can trust.


In the U.S., people find our products in Sephora and SoulCycle as well as retail stores throughout the country. We take great care in our sourcing, manufacturing and testing, so that customers know what they are getting. This is a rapidly evolving industry, which means other companies will take shortcuts to take advantage of the market opportunity. We hope, by our example and willingness to cooperate with regulators and policy makers, we can help elevate industry practices to provide excellent products focused on reliability and transparency, not just profit.

  • Many products on the market contain more or less CBD than advertised or unknown added ingredients. We test our products for heavy metals, pesticides and microbial contaminants. We also clearly label our products as containing ‘CBD’ and disclose the amount of CBD in each product. These processes take more time, but they are worth it in the long run.
  • Our hemp-derived U.S. CBD brands Lord Jones™ and Happy Dance™ publish their third-party lab results online so consumers can access their specific batch analysis.

We’ve spent years refining our cannabis production processes under strict regulations in the Canadian market.


We meet high standards for traceability, quality and transparency, so that customers can be assured of a high-quality product. In holding ourselves to high standards, we’ve learned valuable lessons, which have prepared us well should we enter the U.S. market.

Scientific research has come a long way, but more needs to be done. Companies involved in this space should be all-in, examining effects, risks, uses and benefits. At Cronos Group, we are engaging in both understanding the fundamental science of cannabinoids, both individually and in combination, and how they can be leveraged to best deliver on the consumer’s needs. Additionally, we are partnering with leading scientific institutions engaged in fundamental cannabis science to augment and accelerate our internal efforts. Our work spans many aspects of cannabis research from strain development to growing conditions to extraction technology to fermentation to product development, all supported by advances in analytical sciences.

  • We’ve been at this a long time, operating in the strictly regulated Canadian cannabis market since 2013. In fact, we were one of the first companies in Canada to receive a medicinal cannabis license from Health Canada.
  • We have a strong culture of compliance and health and safety across our operations.
  • We have developed strong and sustainable supply chain partnerships and work with suppliers and vendors who share our values. We select and review our partners not only for the quality of the products and services they provide, but also for their commitment to high standards of business ethics and compliance.
  • We meet high standards for traceability, quality and transparency. We clearly label our products as containing THC and CBD and disclose the amount of THC and CBD in each product.
  • We meet strict quality standards set in each jurisdiction where we distribute our cannabis products.









Responsible Marketing








We believe in continuous research to better understand the potential benefits and risks of CBD.


That means we not only conduct our own research, but also support the research of others so we can lead the industry in transparency, reliability and quality. We demonstrate our commitment to responsible marketing by minimizing reach and appeal to those below the legal age of consumption, including through our packaging and our advertising practices.

  • We strive to ensure our hemp-derived CBD products aren't packaged in a way that appeals to those below the legal age of consumption.
  • We strive to create products that offer adults choice, without appealing to those below the legal age of consumption.
  • We require age affirmation to buy our products on our websites.
  • We restrict advertising to limit reach to those below the legal age of consumption.
  • We won’t get ahead of scientific research, so we don’t make health claims about CBD’s benefits without the requisite data or authoritative support.

We believe the cannabis adult-use market is not for those below the legal age of consumption.


Reducing underage use will require more than just adopting and strictly enforcing minimum age of purchase laws. It will require industry and industry partners including retailers to fully adopt responsible retail practices as a core commitment – and the training and infrastructure necessary to fulfill it. Industry must be fully committed to responsible marketing practices for the full array of cannabis products offered to consumers – distinguishing between adult-use products and products prescribed by medical practitioners.

To protect adult consumers, policy makers, regulators and industry must invest in approaches that support responsible adult consumption. Adults should know what's in the products they are consuming.

  • We support minimizing reach and potential appeal to audiences below the legal age of consumption through responsible packaging and adult-use marketing practices.
  • We believe those below the legal age of consumption should never be targeted in an adult-use cannabis market.
  • If we enter the U.S. market, we intend to engage in youth access prevention measures, and ensure adult consumers receive accurate information about product contents. We are already undertaking such efforts in Canada.
  • In the medicinal context, we support marketing practices that are appropriately tailored and regulated to support the role these products may play in helping patients seeking their benefits, including accurate ingredient disclosures. Individuals should consult with their medical practitioner when seeking advice on medicinal cannabis.
  • We encourage industry cannabis literacy programs, non-profit campaigns, and government education programs that educate consumers on products and responsible consumption.